Evolent Health, Inc.
EVH· NYSE
Released Nov 5, 2019, after the close
10-Q filed Nov 5, 2019, 36 days after period end · 0001628908-19-000072
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $220.14M | $149.95M | $107.91M | — |
| Net Income | -$25.52M | -$12.43M | -$12.59M | -$11.21M |
| EPS Diluted |
Evolent Health, Inc. · CIK 1628908 · Engraved from SEC EDGAR
| -$0.30 |
| -$0.16 |
| -$0.18 |
| -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.